Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
29 mai 2024 16h46 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Biogen Inc. (Nasdaq: BIIB)...
BIOGEN ALERT: BFA Law Announces Biogen Inc. (Nasdaq: BIIB) Sued for Securities Fraud after Significant Stock Drops - Contact the Firm if You Suffered Losses
29 mai 2024 15h16 HE
|
Bleichmar Fonti & Auld
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities Class Action...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
29 mai 2024 12h30 HE
|
Schall Law
The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
28 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
28 mai 2024 14h30 HE
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
24 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Biogen...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.
24 mai 2024 12h30 HE
|
Bernstein Liebhard LLP
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
23 mai 2024 15h48 HE
|
Schall Law
The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Biogen Stockholders and Encourages Investors to Contact the Firm
24 févr. 2024 02h30 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Biogen Inc. (“Biogen” or...
Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen’s Leqembi, According to Spherix Global Insights Neurologist Survey
22 févr. 2024 15h04 HE
|
Spherix Global Insights
EXTON, PA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The 2023 announcement of newly approved disease-modifying therapy (DMT) Leqembi (lecanemab) for Alzheimer’s Disease (AD) sparked eager anticipation...